United Bank Amgen Inc Transaction History

United Bank

$857 Million
Q3 2024

A detailed history of United Bank transactions in Amgen Inc stock. As of the latest transaction made, United Bank holds 53,276 shares of AMGN stock, worth $14.8 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares

53,276

Previous 53,417 0.26%

Holding current value

$14.8 Million

Previous $16.7 Million 2.85%

% of portfolio

2.0%

Previous 2.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$309.38 - $337.38 $43,622 - $47,570	-141 Reduced 0.26%	53,276 $17.2 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $959,563 - $1.17 Million	-3,652 Reduced 6.4%	53,417 $16.7 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $1.48 Million - $1.78 Million	-5,498 Reduced 8.79%	57,069 $16.2 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $60,856 - $68,653	-238 Reduced 0.38%	62,567 $18 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $171,421 - $212,824	-784 Reduced 1.23%	62,805 $16.9 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $658,880 - $779,112	-3,075 Reduced 4.61%	63,589 $14.1 Million
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $74,962 - $91,366	332 Added 0.5%	66,664 $16.1 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $187,804 - $238,628	820 Added 1.25%	66,332 $17.4 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $65,542 - $73,919	292 Added 0.45%	65,512 $14.8 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $177,185 - $197,176	768 Added 1.19%	65,220 $15.9 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $71,262 - $78,835	325 Added 0.51%	64,452 $15.6 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $895,357 - $1.02 Million	-4,502 Reduced 6.56%	64,127 $14.4 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $165,782 - $194,234	781 Added 1.15%	68,629 $14.6 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $25,460 - $28,246	-109 Reduced 0.16%	67,848 $16.5 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $413,196 - $481,513	1,862 Added 2.82%	67,957 $16.9 Million
Q4 2020 Feb 18, 2021	BUY	$216.38 - $257.67 $541,815 - $645,205	2,504 Added 3.94%	66,095 $15.2 Million
Q3 2020 Dec 11, 2020	BUY	$234.65 - $260.95 $40,125 - $44,622	171 Added 0.27%	63,591 $16.2 Million
Q2 2020 Sep 18, 2020	BUY	$197.81 - $242.74 $563,956 - $692,051	2,851 Added 4.71%	63,420 $15 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $180,599 - $239,524	991 Added 1.66%	60,569 $12.3 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $247,865 - $318,592	-1,310 Reduced 2.15%	59,578 $14.4 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $954,122 - $1.14 Million	-5,480 Reduced 8.26%	60,888 $11.8 Million
Q2 2019 Aug 15, 2019	BUY	$166.7 - $195.41 $1.54 Million - $1.81 Million	9,252 Added 16.2%	66,368 $12.2 Million
Q1 2019 May 16, 2019	SELL	$180.87 - $203.88 $183,221 - $206,530	-1,013 Reduced 1.74%	57,116 $10.9 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $196,953 - $229,908	1,104 Added 1.94%	58,129 $11.3 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $84,121 - $94,836	-454 Reduced 0.79%	57,025 $11.8 Million
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $23,080 - $25,924	139 Added 0.24%	57,479 $10.6 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $217,039 - $253,638	1,281 Added 2.29%	57,340 $9.78 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $4.91 Million - $5.48 Million	29,083 Added 107.81%	56,059 $9.75 Million
Q3 2017 Oct 27, 2017	SELL	$167.29 - $191.0 $268,500 - $306,555	-1,605 Reduced 5.62%	26,976 $5.03 Million
Q2 2017 Aug 23, 2017	BUY	N/A	28,581	28,581 $4.92 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.

Account